Short Stack

ACTIVE INGREDIENT

Each mL contains:

• Trenbolone Acetate 50 mg
• Drostanolone Propionate 50 mg
• Testosterone Propionate 100 mg

DESCRIPTION

Short Stack 250 mg is an injectable anabolic steroid blend formulated to provide a potent combination of trenbolone acetate, drostanolone propionate, and testosterone propionate. This blend is designed for rapid muscle gain, fat loss, and enhanced performance, making it popular among bodybuilders and athletes. Trenbolone acetate offers significant anabolic effects, while drostanolone propionate enhances muscle hardness and definition, and testosterone propionate supports overall testosterone levels for improved strength and recovery.

PHARMACOLOGICAL PROPERTIES

Mechanism of Action: The components of Short Stack bind to androgen receptors, leading to increased protein synthesis, nitrogen retention, and enhanced muscle growth. This combination promotes lean muscle mass while minimizing fat accumulation and water retention.

Pharmacokinetics:

• Absorption: Provides a rapid onset of action due to the inclusion of short-acting esters.
• Distribution: Distributed widely in tissues, with high binding affinity for plasma proteins.
• Metabolism: Primarily metabolized in the liver.
• Excretion: Excreted mainly through urine as metabolites.

INDICATIONS

Short Stack 250 mg is indicated for:

Performance enhancement: Used in bodybuilding and athletics to increase muscle mass, strength, and performance.

Body composition improvement: Aimed at reducing body fat while enhancing muscle definition and hardness.

DOSAGE AND ADMINISTRATION

Dosage:

• Anabolic/Bodybuilding Use: Common doses range from 250 mg to 600 mg per week, divided into two to three administrations. Dosage should be tailored to the individual’s experience, goals, and tolerance.

Administration:

• Administer via deep intramuscular injection. Rotate injection sites regularly to avoid localized irritation or pain. Shake the vial well before administration to ensure uniform suspension.

CONTRAINDICATIONS

• Hypersensitivity to any component of the formulation.
• Pregnancy and lactation (Pregnancy Category X).
• Active or suspected prostate cancer in males.
• Severe cardiovascular, renal, or hepatic disease.

WARNINGS AND PRECAUTIONS

1. Hepatic Toxicity: Short Stack may cause liver toxicity, including liver enzyme elevations. Regular liver function tests are recommended, especially during long-term use.

2. Cardiovascular Risks: Use of anabolic steroids may increase the risk of cardiovascular disease, including hypertension and dyslipidemia. Monitor cardiovascular health closely, particularly in long-term users.

3. Androgenic Effects: Androgenic side effects such as acne, hair loss, and virilization in women (deepening of the voice, facial hair growth, etc.) may occur.

4. Lipid Profile: Short Stack may negatively impact cholesterol levels, lowering HDL (good cholesterol) and raising LDL (bad cholesterol). Regular monitoring of lipid profiles is recommended.

5. Mood Changes: Users may experience changes in mood, including aggression, irritability, and mood swings.

ADVERSE REACTIONS

Common adverse reactions:

• Acne
• Oily skin
• Hair loss (androgenic alopecia)
• Increased sweating
• Sleep disturbances

Serious adverse reactions:

• Hepatotoxicity: Liver damage and jaundice.
• Cardiovascular: Increased risk of heart attack, stroke, or blood clot formation.
• Endocrine: Gynecomastia (in men), suppression of natural testosterone production, testicular atrophy.
• Psychiatric: Aggression, irritability, mood swings, or depression.

INTERACTIONS

1. Anticoagulants: Short Stack can enhance the effects of anticoagulants (e.g., warfarin), increasing the risk of bleeding. Close monitoring of blood coagulation is necessary.

2. Insulin and Oral Antidiabetics: Short Stack can impact glucose tolerance and may require adjustments to insulin or antidiabetic medication dosages.

3. Corticosteroids: Combined use of corticosteroids with Short Stack may increase the risk of fluid retention and exacerbate electrolyte imbalances.

USE IN SPECIFIC POPULATIONS

Pregnancy and Lactation: Short Stack is contraindicated in pregnant and breastfeeding women due to its potential teratogenic effects (Pregnancy Category X).

Pediatric Use: Use in children or adolescents may interfere with normal growth and development due to the risk of premature closure of the growth plates (epiphyseal closure).

Geriatric Use: Older individuals may be more susceptible to adverse effects, particularly on the liver and cardiovascular system. Use with caution in elderly patients.

OVERDOSAGE

There is no specific antidote for Short Stack overdose. In case of an overdose, supportive and symptomatic treatment should be provided. Monitor liver function and cardiovascular health closely.

STORAGE

Store below 25°C (77°F). Protect from light. Do not refrigerate or freeze. Keep out of reach of children.

PACKAGING

Short Stack 250 mg is supplied in 1 mL ampoules or vials, each containing 250 mg of trenbolone, drostanolone, and testosterone in an oil-based suspension.

MANUFACTURER

Oxydine Metabolics Switzerland

Oxydine.org
Hi@Oxydine.org